{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T05:40:19Z","timestamp":1773898819930,"version":"3.50.1"},"reference-count":136,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T00:00:00Z","timestamp":1542758400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Iraqi Government"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Cell Commun. Signal."],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s12079-018-0494-y","type":"journal-article","created":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T21:01:47Z","timestamp":1542834107000},"page":"421-434","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Molecular signatures for CCN1, p21 and p27 in progressive mantle cell lymphoma"],"prefix":"10.1002","volume":"13","author":[{"given":"Afak Rasheed Salman","family":"Zaidi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadie","family":"Dresman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Burt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Rule","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8328-3936","authenticated-orcid":false,"given":"Lynn","family":"McCallum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,11,21]]},"reference":[{"issue":"6","key":"494_CR1","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nrc2657","volume":"9","author":"T Abbas","year":"2009","unstructured":"Abbas T, Dutta A (2009) p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 9(6):400\u2013414","journal-title":"Nat Rev Cancer"},{"key":"494_CR2","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1017\/S1462399408000744","volume":"10","author":"AM Abukhdeir","year":"2008","unstructured":"Abukhdeir AM, Park BH (2008) P21 and p27: roles in carcinogenesis and drug resistance. Expert Rev Mol Med 10:e19","journal-title":"Expert Rev Mol Med"},{"issue":"7","key":"494_CR3","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.tcb.2008.05.002","volume":"18","author":"RK Assoian","year":"2008","unstructured":"Assoian RK, Klein EA (2008) Growth control by intracellular tension and extracellular stiffness. Trends Cell Biol 18(7):347\u2013352","journal-title":"Trends Cell Biol"},{"issue":"6","key":"494_CR4","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.4049\/jimmunol.0902792","volume":"184","author":"T Bai","year":"2010","unstructured":"Bai T, Chen C-C, Lau LF (2010) Matricellular protein CCN1 activates a proinflammatory genetic program in murine macrophages. J Immunol 184(6):3223\u20133232","journal-title":"J Immunol"},{"issue":"1","key":"494_CR5","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13045-017-0447-6","volume":"10","author":"P Balsas","year":"2017","unstructured":"Balsas P, Esteve-Arenys A, Rold\u00e1n J, Jim\u00e9nez L, Rodr\u00edguez V, Valero JG, Chamorro-Jorganes A, de la Bellacasa RP, Teixid\u00f3 J, Matas-C\u00e9spedes A, Moros A, Mart\u00ednez A, Campo E, S\u00e1ez-Border\u00edas A, Borrell JI, P\u00e9rez-Gal\u00e1n P, Colomer D, Rou\u00e9 G (2017) Activity of the novel BCR kinase inhibitor IQS019 in preclinical models of B-cell non-Hodgkin lymphoma. J Hematol Oncol 10(1):80","journal-title":"J Hematol Oncol"},{"issue":"3\u20134","key":"494_CR6","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/sj.bjc.6690390","volume":"80","author":"G Baretton","year":"1999","unstructured":"Baretton G, Klenk U, Diebold J, Schmeller N, L\u00f6hrs U (1999) Proliferation-and apoptosis-associated factors in advanced prostatic carcinomas before and after androgen deprivation therapy: prognostic significance of p21\/WAF1\/CIP1 expression. Br J Cancer 80(3\u20134):546\u2013555","journal-title":"Br J Cancer"},{"issue":"1","key":"494_CR7","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.canlet.2006.02.019","volume":"246","author":"L Bartholin","year":"2007","unstructured":"Bartholin L, Wessner LL, Chirgwin JM, Guise TA (2007) The human Cyr61 gene is a transcriptional target of transforming growth factor beta in cancer cells. Cancer Lett 246(1):230\u2013236","journal-title":"Cancer Lett"},{"issue":"45","key":"494_CR8","doi-asserted-by":"publisher","first-page":"18250","DOI":"10.1073\/pnas.1314608110","volume":"110","author":"S Be\u00e0","year":"2013","unstructured":"Be\u00e0 S, Vald\u00e9s-Mas R, Navarro A, Salaverria I, Mart\u00edn-Garcia D, Jares P, Gin\u00e9 E, Pinyol M, Royo C, Nadeu F, Conde L, Juan M, Clot G, Viz\u00e0n P, Croce LD, Puente DA, L\u00f3pez-Guerra M, Moros A, Roue G, Aymerich M, Villamor N, Colomo L, Mart\u00ednez A, Valera A, Mart\u00edn-Subero JI, Amador V, Hern\u00e0ndez L, Rozman M, Enjuanes A, Forcada P, Munta\u00f1ola A, Hartmann EM, Calasanz MJ, Rosenwald A, Ott G, Hern\u00e0ndez-Rivas JM, Klapper W, Siebert R, Wiestner A, Wilson WH, Colomer D, L\u00f3pez-Guillermo A, L\u00f3pez-Otin C, Puente XS, Campo E (2013) Landscape of somatic mutations and clonal evolution in mantle cell lymphoma. Proc Natl Acad Sci U S A 110(45):18250\u201318255","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"494_CR9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.devcel.2008.01.013","volume":"14","author":"A Besson","year":"2008","unstructured":"Besson A, Dowdy SF, Roberts JM (2008) CDK inhibitors: cell cycle regulators and beyond. Dev Cell 14(2):159\u2013169","journal-title":"Dev Cell"},{"issue":"2","key":"494_CR10","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1054\/ijom.2001.0214","volume":"31","author":"P Brennan","year":"2002","unstructured":"Brennan P, Palacios-Callender M, Umar T, Tant S, Langdon J (2002) Expression of type 2 nitric oxide synthase and p21 in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 31(2):200\u2013205","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"5","key":"494_CR11","first-page":"506","volume":"1849","author":"G Bretones","year":"2015","unstructured":"Bretones G, Delgado MD, Le\u00f3n J (2015) Myc and cell cycle control. BBA Gene Regulatory Mechanisms 1849(5):506\u2013516","journal-title":"BBA Gene Regulatory Mechanisms"},{"issue":"1","key":"494_CR12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1182\/blood-2014-05-521898","volume":"125","author":"E Campo","year":"2015","unstructured":"Campo E, Rule S (2015) Mantle cell lymphoma: evolving management strategies. Blood 125(1):48\u201355","journal-title":"Blood"},{"issue":"8","key":"494_CR13","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.leukres.2005.11.013","volume":"30","author":"J Camps","year":"2006","unstructured":"Camps J, Salaverria I, Garcia MJ, Prat E, Be\u00e0 S, Pole JC, Hern\u00e1ndez L, Del Rey J, Cigudosa JC, Bernu\u00e9s M (2006) Genomic imbalances and patterns of karyotypic variability in mantle-cell lymphoma cell lines. Leuk Res 30(8):923\u2013934","journal-title":"Leuk Res"},{"issue":"7","key":"494_CR14","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.clml.2015.02.021","volume":"15","author":"RD Cassaday","year":"2015","unstructured":"Cassaday RD, Goy A, Advani S, Chawla P, Nachankar R, Gandhi M, Gopal AK (2015) A phase II, single-arm, open-label, multicenter study to evaluate the efficacy and safety of P276-00, a cyclin-dependent kinase inhibitor, in patients with relapsed or refractory mantle cell lymphoma. Clin Lymphoma Myeloma Leuk 15(7):392\u2013397","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"2","key":"494_CR15","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/1097-0215(20010320)95:2<128::AID-IJC1022>3.0.CO;2-D","volume":"95","author":"C Ceccarelli","year":"2001","unstructured":"Ceccarelli C, Santini D, Chieco P, Lanciotti C, Taffurelli M, Paladini G, Marrano D (2001) Quantitative p21WAF-1\/p53 immunohistochemical analysis defines groups of primary invasive breast carcinomas with different prognostic indicators. Int J Cancer 95(2):128\u2013134","journal-title":"Int J Cancer"},{"key":"494_CR16","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1002\/jcb.21194","volume":"100","author":"Y Chen","year":"2007","unstructured":"Chen Y, Du X (2007) Functional properties and intracellular signaling of CCN1\/Cyr61. J Cell Biochem 100:1337\u20131345","journal-title":"J Cell Biochem"},{"issue":"10","key":"494_CR17","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1158\/1055-9965.EPI-11-0472","volume":"20","author":"G Chen","year":"2011","unstructured":"Chen G, Cheng Y, Zhang Z, Martinka M, Li G (2011) Prognostic significance of cytoplasmic p27 expression in human melanoma. Cancer Epidemiol Biomark Prev 20(10):2212\u20132221","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"7","key":"494_CR18","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.3748\/wjg.v20.i7.1694","volume":"20","author":"T-Y Cheng","year":"2014","unstructured":"Cheng T-Y, Wu M-S, Hua K-T, Kuo M-L, Lin M-T (2014) Cyr61\/CTGF\/Nov family proteins in gastric carcinogenesis. World J Gastroenterol 20(7):1694\u20131700","journal-title":"World J Gastroenterol"},{"issue":"51","key":"494_CR19","doi-asserted-by":"publisher","first-page":"53087","DOI":"10.1074\/jbc.M410254200","volume":"279","author":"W Chien","year":"2004","unstructured":"Chien W, Kumagai T, Miller CW, Desmond JC, Frank JM, Said JW, Koeffler HP (2004) Cyr61 suppresses growth of human endometrial cancer cells. J Biol Chem 279(51):53087\u201353096","journal-title":"J Biol Chem"},{"issue":"32","key":"494_CR20","doi-asserted-by":"publisher","first-page":"23075","DOI":"10.1074\/jbc.M113.475418","volume":"288","author":"J Choi","year":"2013","unstructured":"Choi J, Lin A, Shrier E, Lau LF, Grant MB, Chaqour B (2013) Degradome products of the matricellular protein CCN1 as modulators of pathological angiogenesis in the retina. J Biol Chem 288(32):23075\u201323089","journal-title":"J Biol Chem"},{"issue":"1","key":"494_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1476-4598-4-41","volume":"4","author":"C Ciccarelli","year":"2005","unstructured":"Ciccarelli C, Marampon F, Scoglio A, Mauro A, Giacinti C, De Cesaris P, Zani BM (2005) p21WAF1 expression induced by MEK\/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells. Mol Cancer 4(1):41","journal-title":"Mol Cancer"},{"issue":"5263","key":"494_CR22","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1126\/science.272.5263.877","volume":"272","author":"S Coats","year":"1996","unstructured":"Coats S, Flanagan WM, Nourse J, Roberts JM (1996) Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science 272(5263):877\u2013880","journal-title":"Science"},{"issue":"3","key":"494_CR23","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s12079-016-0342-x","volume":"10","author":"LJ Crawford","year":"2016","unstructured":"Crawford LJ, Irvine AE (2016) The role of the CCN family of proteins in blood cancers. J Cell Commun Signal 10(3):197\u2013205","journal-title":"J Cell Commun Signal"},{"issue":"12","key":"494_CR24","doi-asserted-by":"publisher","first-page":"5761","DOI":"10.1210\/en.2007-0473","volume":"148","author":"JC Crockett","year":"2007","unstructured":"Crockett JC, Sch\u00fctze N, Tosh D, Jatzke S, Duthie A, Jakob F, Rogers MJ (2007) The matricellular protein CYR61 inhibits osteoclastogenesis by a mechanism independent of \u03b1v\u03b23 and \u03b1v\u03b25. Endocrinology 148(12):5761\u20135768","journal-title":"Endocrinology"},{"issue":"4","key":"494_CR25","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.juro.2009.12.006","volume":"183","author":"KB D'Antonio","year":"2010","unstructured":"D'Antonio KB, Toubaji A, Albadine R, Mondul AM, Platz EA, Netto GJ, Getzenberg RH (2010) Extracellular matrix associated protein CYR61 is linked to prostate cancer development. J Urol 183(4):1604\u20131610","journal-title":"J Urol"},{"issue":"5","key":"494_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0097434","volume":"9","author":"C Renty de","year":"2014","unstructured":"de Renty C, DePamphilis ML, Ullah Z (2014) Cytoplasmic localization of p21 protects trophoblast giant cells from DNA damage induced apoptosis. PLoS One 9(5):e97434","journal-title":"PLoS One"},{"issue":"19","key":"494_CR27","doi-asserted-by":"publisher","first-page":"9238","DOI":"10.1158\/0008-5472.CAN-07-1375","volume":"67","author":"C Denicourt","year":"2007","unstructured":"Denicourt C, Saenz CC, Datnow B, Cui X-S, Dowdy SF (2007) Relocalized p27Kip1 tumor suppressor functions as a cytoplasmic metastatic oncogene in melanoma. Cancer Res 67(19):9238\u20139243","journal-title":"Cancer Res"},{"issue":"12","key":"494_CR28","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1101\/gad.341405","volume":"19","author":"V Devgan","year":"2005","unstructured":"Devgan V, Mammucari C, Millar SE, Brisken C, Dotto GP (2005) p21WAF1\/Cip1 is a negative transcriptional regulator of Wnt4 expression downstream of Notch1 activation. Genes Dev 19(12):1485\u20131495","journal-title":"Genes Dev"},{"issue":"38","key":"494_CR29","doi-asserted-by":"publisher","first-page":"26194","DOI":"10.1074\/jbc.M109.019836","volume":"284","author":"AS Dobroff","year":"2009","unstructured":"Dobroff AS, Wang H, Melnikova VO, Villares GJ, Zigler M, Huang L, Bar-Eli M (2009) Silencing cAMP-response element-binding protein (CREB) identifies CYR61 as a tumor suppressor gene in melanoma. J Biol Chem 284(38):26194\u201326206","journal-title":"J Biol Chem"},{"issue":"1","key":"494_CR30","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1478-811X-12-36","volume":"12","author":"J Dotterweich","year":"2014","unstructured":"Dotterweich J, Ebert R, Kraus S, Tower RJ, Jakob F, Sch\u00fctze N (2014) Mesenchymal stem cell contact promotes CCN1 splicing and transcription in myeloma cells. Cell Commun Signal 12(1):36","journal-title":"Cell Commun Signal"},{"issue":"8","key":"494_CR31","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1080\/10428194.2017.1403602","volume":"59","author":"M Dreyling","year":"2018","unstructured":"Dreyling M, Aurer I, Cortelazzo S, Hermine O, Hess G, Jerkeman M, Le Gouill S, Ribrag V, Trn\u011bn\u00fd M, Visco C, Walewski J, Zaja F, Zinzani PL (2018) Treatment for patients with relapsed\/refractory mantle cell lymphoma: European-based recommendations. Leuk Lymphoma 59(8):1814\u20131828","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"494_CR32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/PGP.0b013e3181b64ec3","volume":"29","author":"TJ Duncan","year":"2010","unstructured":"Duncan TJ, Al-Attar A, Rolland P, Harper S, Spendlove I, Durrant LG (2010) Cytoplasmic p27 expression is an independent prognostic factor in ovarian cancer. Int J Gynecol Pathol 29(1):8\u201318","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"494_CR33","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.biocel.2007.06.020","volume":"40","author":"P Feng","year":"2008","unstructured":"Feng P, Wang B, Ren EC (2008) Cyr61\/CCN1 is a tumor suppressor in human hepatocellular carcinoma and involved in DNA damage response. Int J Biochem Cell Biol 40(1):98\u2013109","journal-title":"Int J Biochem Cell Biol"},{"issue":"6","key":"494_CR34","first-page":"1231","volume":"17","author":"G Ferrandina","year":"2000","unstructured":"Ferrandina G, Stoler A, Fagotti A, Fanfani F, Sacco R, De Pasqua A, Mancuso S, Scambia G (2000) p21WAF1\/CIP1 protein expression in primary ovarian cancer. Int J Oncol 17(6):1231\u20131236","journal-title":"Int J Oncol"},{"issue":"12","key":"494_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.0030219","volume":"3","author":"CM Garrett-Engele","year":"2007","unstructured":"Garrett-Engele CM, Tasch MA, Hwang HC, Fero ML, Perlmutter RM, Clurman BE, Roberts JM (2007) A mechanism misregulating p27 in tumors discovered in a functional genomic screen. PLoS Genet 3(12):e219","journal-title":"PLoS Genet"},{"issue":"13","key":"494_CR36","doi-asserted-by":"publisher","first-page":"5171","DOI":"10.1182\/blood-2008-02-139212","volume":"112","author":"P Gelebart","year":"2008","unstructured":"Gelebart P, Anand M, Armanious H, Peters AC, Bard JD, Amin HM, Lai R (2008) Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma. Blood 112(13):5171\u20135179","journal-title":"Blood"},{"issue":"20","key":"494_CR37","doi-asserted-by":"publisher","first-page":"7243","DOI":"10.1158\/1078-0432.CCR-05-0231","volume":"11","author":"S Gery","year":"2005","unstructured":"Gery S, Xie D, Yin D, Gabra H, Miller C, Wang H, Scott D, William SY, Popoviciu ML, Said JW (2005) Ovarian carcinomas: CCN genes are aberrantly expressed and CCN1 promotes proliferation of these cells. Clin Cancer Res 11(20):7243\u20137254","journal-title":"Clin Cancer Res"},{"issue":"2","key":"494_CR38","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/(SICI)1097-0215(19960422)69:2<92::AID-IJC4>3.0.CO;2-Q","volume":"69","author":"C Gillett","year":"1996","unstructured":"Gillett C, Smith P, Gregory W, Richards M, Millis R, Peters G, Barnes D (1996) Cyclin D1 and prognosis in human breast cancer. Int J Cancer 69(2):92\u201399","journal-title":"Int J Cancer"},{"key":"494_CR39","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0065-230X(08)60352-8","volume":"68","author":"M Hall","year":"1996","unstructured":"Hall M, Peters G (1996) Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv Cancer Res 68:67\u2013108","journal-title":"Adv Cancer Res"},{"issue":"46","key":"494_CR40","doi-asserted-by":"publisher","first-page":"38569","DOI":"10.1074\/jbc.M112.389064","volume":"287","author":"I Haque","year":"2012","unstructured":"Haque I, De A, Majumder M, Mehta S, McGregor D, Banerjee SK, Van Veldhuizen P, Banerjee S (2012) The matricellular protein CCN1\/Cyr61 is a critical regulator of Sonic Hedgehog in pancreatic carcinogenesis. J Biol Chem 287(46):38569\u201338579","journal-title":"J Biol Chem"},{"issue":"7","key":"494_CR41","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1089\/cbr.2010.0802","volume":"27","author":"W He","year":"2012","unstructured":"He W, Wang X, Chen L, Guan X (2012) A crosstalk imbalance between p27kip1 and its interacting molecules enhances breast carcinogenesis. Cancer Biother Radiopharm 27(7):399\u2013402","journal-title":"Cancer Biother Radiopharm"},{"issue":"3","key":"494_CR42","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1182\/blood.V86.3.841.841","volume":"86","author":"T Hirama","year":"1995","unstructured":"Hirama T, Koeffler HP (1995) Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood 86(3):841\u2013854","journal-title":"Blood"},{"issue":"3","key":"494_CR43","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jamcollsurg.2004.10.005","volume":"200","author":"SE Holloway","year":"2005","unstructured":"Holloway SE, Beck AW, Girard L, Jaber MR, Barnett CC, Brekken RA, Fleming JB (2005) Increased expression of Cyr61 (CCN1) identified in peritoneal metastases from human pancreatic cancer. J Am Coll Surg 200(3):371\u2013377","journal-title":"J Am Coll Surg"},{"issue":"10","key":"494_CR44","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.5858\/2000-124-1457-MIAOTC","volume":"124","author":"KF Izban","year":"2000","unstructured":"Izban KF, Alkan S, Singleton TP, Hsi ED (2000) Multiparameter immunohistochemical analysis of the cell cycle proteins cyclin D1, Ki-67, p21WAF1, p27KIP1, and p53 in mantle cell lymphoma. Arch Pathol Lab Med 124(10):1457\u20131462","journal-title":"Arch Pathol Lab Med"},{"issue":"8","key":"494_CR45","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/cbf.2853","volume":"30","author":"J Jandova","year":"2012","unstructured":"Jandova J, Beyer TE, Meuillet EJ, Watts GS (2012) The matrix protein CCN1\/CYR61 is required for \u03b1V\u03b25-mediated cancer cell migration. Cell Biochem Funct 30(8):687\u2013695","journal-title":"Cell Biochem Funct"},{"issue":"10","key":"494_CR46","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1172\/JCI61272","volume":"122","author":"P Jares","year":"2012","unstructured":"Jares P, Colomer D, Campo E (2012) Molecular pathogenesis of mantle cell lymphoma. J Clin Invest 122(10):3416\u20133423","journal-title":"J Clin Invest"},{"issue":"34","key":"494_CR47","doi-asserted-by":"publisher","first-page":"35880","DOI":"10.18632\/oncotarget.5770","volume":"6","author":"P Jeannot","year":"2015","unstructured":"Jeannot P, Callot C, Baer R, Duquesnes N, Guerra C, Guillermet-Guibert J, Bachs O, Besson A (2015) Loss of p27Kip1 promotes metaplasia in the pancreas via the regulation of Sox9 expression. Oncotarget 6(34):35880","journal-title":"Oncotarget"},{"issue":"34","key":"494_CR48","doi-asserted-by":"publisher","first-page":"24321","DOI":"10.1074\/jbc.274.34.24321","volume":"274","author":"A Jedsadayanmata","year":"1999","unstructured":"Jedsadayanmata A, Chen C-C, Kireeva ML, Lau LF, Lam SC-T (1999) Activation-dependent adhesion of human platelets to Cyr61 and Fisp12\/mouse connective tissue growth factor is mediated through integrin \u03b1IIb\u03b23. J Biol Chem 274(34):24321\u201324327","journal-title":"J Biol Chem"},{"issue":"1","key":"494_CR49","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/1471-2407-14-164","volume":"14","author":"D Jeong","year":"2014","unstructured":"Jeong D, Heo S, Ahn TS, Lee S, Park S, Kim H, Park D, Bae SB, Lee SS, Lee MS (2014) Cyr61 expression is associated with prognosis in patients with colorectal cancer. BMC Cancer 14(1):164","journal-title":"BMC Cancer"},{"issue":"9","key":"494_CR50","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1002\/jcb.24557","volume":"114","author":"SJ Jim Leu","year":"2013","unstructured":"Jim Leu SJ, Sung JS, Chen MY, Chen CW, Cheng JY, Wang TY, Wang JJ (2013) The matricellular protein CCN1 suppresses lung cancer cell growth by inducing senescence via the p53\/p21 pathway. J Cell Biochem 114(9):2082\u20132093","journal-title":"J Cell Biochem"},{"issue":"13","key":"494_CR51","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1182\/blood-2014-02-555813","volume":"124","author":"SK Johnson","year":"2014","unstructured":"Johnson SK, Stewart JP, Bam R, Qu P, Barlogie B, van Rhee F, Shaughnessy JD Jr, Epstein J, Yaccoby S (2014) CYR61\/CCN1 overexpression in the myeloma microenvironment is associated with superior survival and reduced bone disease. Blood 124(13):2051\u20132060","journal-title":"Blood"},{"issue":"10","key":"494_CR52","first-page":"2021","volume":"11","author":"J-M Jung","year":"1995","unstructured":"Jung J-M, Bruner JM, Ruan S, Langford LA, Kyritsis AP, Kobayashi T, Levin VA, Zhang W (1995) Increased levels of p21WAF1\/Cip1 in human brain tumors. Oncogene 11(10):2021\u20132028","journal-title":"Oncogene"},{"issue":"1B","key":"494_CR53","first-page":"521","volume":"21","author":"N Kapranos","year":"2000","unstructured":"Kapranos N, Stathopoulos G, Manolopoulos L, Kokka E, Papadimitriou C, Bibas A, Yiotakis J, Adamopoulos G (2000) p53, p21 and p27 protein expression in head and neck cancer and their prognostic value. Anticancer Res 21(1B):521\u2013528","journal-title":"Anticancer Res"},{"issue":"1\u20132","key":"494_CR54","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/19336918.2016.1139265","volume":"10","author":"F Kipkeew","year":"2016","unstructured":"Kipkeew F, Kirsch M, Klein D, Wuelling M, Winterhager E, Gellhaus A (2016) CCN1 (CYR61) and CCN3 (NOV) signaling drives human trophoblast cells into senescence and stimulates migration properties. Cell Adhes Migr 10(1\u20132):163\u2013178","journal-title":"Cell Adhes Migr"},{"issue":"4","key":"494_CR55","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1128\/MCB.16.4.1326","volume":"16","author":"ML Kireeva","year":"1996","unstructured":"Kireeva ML, Mo F-E, Yang GP, Lau LF (1996) Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion. Mol Cell Biol 16(4):1326\u20131334","journal-title":"Mol Cell Biol"},{"issue":"10","key":"494_CR56","first-page":"1831","volume":"3","author":"T Komiya","year":"1997","unstructured":"Komiya T, Hosono Y, Hirashima T, Masuda N, Yasumitsu T, Nakagawa K, Kikui M, Ohno A, Fukuoka M, Kawase I (1997) p21 expression as a predictor for favorable prognosis in squamous cell carcinoma of the lung. Clin Cancer Res 3(10):1831\u20131835","journal-title":"Clin Cancer Res"},{"issue":"9","key":"494_CR57","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1182\/blood-2011-11-391474","volume":"119","author":"R Kridel","year":"2012","unstructured":"Kridel R, Meissner B, Rogic S, Boyle M, Telenius A, Woolcock B, Gunawardana J, Jenkins C, Cochrane C, Ben-Neriah S (2012) Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma. Blood 119(9):1963\u20131971","journal-title":"Blood"},{"issue":"10","key":"494_CR58","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1111\/j.1464-410X.2011.10649.x","volume":"109","author":"S Kruck","year":"2012","unstructured":"Kruck S, Merseburger AS, Hennenlotter J, Scharpf M, Eyrich C, Amend B, Sievert KD, Stenzl A, Bedke J (2012) High cytoplasmic expression of p27Kip1 is associated with a worse cancer-specific survival in clear cell renal cell carcinoma. BJU Int 109(10):1565\u20131570","journal-title":"BJU Int"},{"issue":"7","key":"494_CR59","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1101\/gad.11.7.847","volume":"11","author":"J LaBaer","year":"1997","unstructured":"LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, Fattaey A, Harlow E (1997) New functional activities for the p21 family of CDK inhibitors. Genes Dev 11(7):847\u2013862","journal-title":"Genes Dev"},{"issue":"19","key":"494_CR60","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1007\/s00018-011-0778-3","volume":"68","author":"LF Lau","year":"2011","unstructured":"Lau LF (2011) CCN1\/CYR61: the very model of a modern matricellular protein. Cell Mol Life Sci 68(19):3149\u20133163","journal-title":"Cell Mol Life Sci"},{"issue":"42","key":"494_CR61","doi-asserted-by":"publisher","first-page":"44177","DOI":"10.1074\/jbc.M407850200","volume":"279","author":"S-J Leu","year":"2004","unstructured":"Leu S-J, Chen N, Chen C-C, Todorovi\u0107 V, Bai T, Juric V, Liu Y, Yan G, Lam SC-T, Lau LF (2004) Targeted mutagenesis of the angiogenic protein CCN1 (CYR61) selective inactivation of integrin \u03b16\u03b21-heparan sulfate proteoglycan coreceptor-mediated cellular functions. J Biol Chem 279(42):44177\u201344187","journal-title":"J Biol Chem"},{"issue":"4","key":"494_CR62","doi-asserted-by":"publisher","first-page":"e35754","DOI":"10.1371\/journal.pone.0035754","volume":"7","author":"Z-Q Li","year":"2012","unstructured":"Li Z-Q, Ding W, Sun S-J, Li J, Pan J, Zhao C, Wu W-R, Si W-K (2012) Cyr61\/CCN1 is regulated by Wnt\/\u03b2-catenin signaling and plays an important role in the progression of hepatocellular carcinoma (Cyr61 is regulated by Wnt and plays a role in HCC). PLoS One 7(4):e35754","journal-title":"PLoS One"},{"issue":"13","key":"494_CR63","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1158\/0008-5472.CAN-15-3189","volume":"76","author":"Y Li","year":"2016","unstructured":"Li Y, Nakka M, Kelly AJ, Lau CC, Krailo M, Barkauskas DA, Hicks JM, Man T-K (2016) p27 is a candidate prognostic biomarker and metastatic promoter in osteosarcoma. Cancer Res 76(13):4002\u20134011","journal-title":"Cancer Res"},{"issue":"23","key":"494_CR64","doi-asserted-by":"publisher","first-page":"24015","DOI":"10.1074\/jbc.M402305200","volume":"279","author":"M-T Lin","year":"2004","unstructured":"Lin M-T, Chang C-C, Chen S-T, Chang H-L, Su J-L, Chau Y-P, Kuo M-L (2004) Cyr61 expression confers resistance to apoptosis in breast cancer MCF-7 cells by a mechanism of NF-\u03baB-dependent XIAP up-regulation. J Biol Chem 279(23):24015\u201324023","journal-title":"J Biol Chem"},{"issue":"47","key":"494_CR65","doi-asserted-by":"publisher","first-page":"34594","DOI":"10.1074\/jbc.M706600200","volume":"282","author":"M-T Lin","year":"2007","unstructured":"Lin M-T, Chang C-C, Lin B-R, Yang H-Y, Chu C-Y, Wu M-H, Kuo M-L (2007) Elevated expression of Cyr61 enhances peritoneal dissemination of gastric cancer cells through integrin \u03b12\u03b21. J Biol Chem 282(47):34594\u201334604","journal-title":"J Biol Chem"},{"key":"494_CR66","first-page":"18","volume":"2","author":"Y Liu","year":"2015","unstructured":"Liu Y, Zhang X, Zhong JF (2015) Current approaches and advance in mantle cell lymphoma treatment. Stem Cell Investig 2:18","journal-title":"Stem Cell Investig"},{"issue":"12","key":"494_CR67","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.4161\/cc.9.12.11988","volume":"9","author":"Z Lu","year":"2010","unstructured":"Lu Z, Hunter T (2010) Ubiquitylation and proteasomal degradation of the p21Cip1, p27Kip1 and p57Kip2 CDK inhibitors. Cell Cycle 9(12):2342\u20132352","journal-title":"Cell Cycle"},{"issue":"12","key":"494_CR68","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1002\/(SICI)1097-0142(19980615)82:12<2409::AID-CNCR15>3.0.CO;2-T","volume":"82","author":"X Lu","year":"1998","unstructured":"Lu X, Toki T, Konishi I, Nikaido T, Fujii S (1998a) Expression of p21WAF1\/CIP1 in adenocarcinoma of the uterine cervix. Cancer 82(12):2409\u20132417","journal-title":"Cancer"},{"issue":"6","key":"494_CR69","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/sj.onc.1201585","volume":"16","author":"Y Lu","year":"1998","unstructured":"Lu Y, Yamagishi N, Yagi T, Takebe H (1998b) Mutated p21 (WAF1\/CIP1\/SDI1) lacking CDK-inhibitory activity fails to prevent apoptosis in human colorectal carcinoma cells. Oncogene 16(6):705\u2013712","journal-title":"Oncogene"},{"issue":"1","key":"494_CR70","first-page":"167","volume":"150","author":"J Lukas","year":"1997","unstructured":"Lukas J, Groshen S, Saffari B, Niu N, Reles A, Wen W-H, Felix J, Jones LA, Hall FL, Press MF (1997) WAF1\/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium. Am J Pathol 150(1):167\u2013175","journal-title":"Am J Pathol"},{"key":"494_CR71","doi-asserted-by":"publisher","first-page":"4995","DOI":"10.1038\/srep04995","volume":"4","author":"G Maity","year":"2014","unstructured":"Maity G, Mehta S, Haque I, Dhar K, Sarkar S, Banerjee SK, Banerjee S (2014) Pancreatic tumor cell secreted CCN1\/Cyr61 promotes endothelial cell migration and aberrant neovascularization. Sci Rep 4:4995. https:\/\/doi.org\/10.1038\/srep04995","journal-title":"Sci Rep"},{"issue":"1","key":"494_CR72","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13045-015-0161-1","volume":"8","author":"R Mathur","year":"2015","unstructured":"Mathur R, Sehgal L, Braun FK, Berkova Z, Romaguerra J, Wang M, Rodriguez MA, Fayad L, Neelapu SS, Samaniego F (2015) Targeting Wnt pathway in mantle cell lymphoma-initiating cells. J Hematol Oncol 8(1):63","journal-title":"J Hematol Oncol"},{"issue":"2","key":"494_CR73","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.blre.2008.07.002","volume":"23","author":"L McCallum","year":"2009","unstructured":"McCallum L, Irvine A (2009) CCN3\u2013a key regulator of the hematopoietic compartment. Blood Rev 23(2):79\u201385","journal-title":"Blood Rev"},{"issue":"5","key":"494_CR74","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/sj.onc.1208238","volume":"24","author":"JA Menendez","year":"2005","unstructured":"Menendez JA, Vellon L, Mehmi I, Teng PK, Griggs DW, Lupu R (2005) A novel CYR61-triggered \u2018CYR61-\u03b1v\u03b23 integrin loop\u2019regulates breast cancer cell survival and chemosensitivity through activation of ERK1\/ERK2 MAPK signaling pathway. Oncogene 24(5):761\u2013779","journal-title":"Oncogene"},{"issue":"15","key":"494_CR75","doi-asserted-by":"publisher","first-page":"5225","DOI":"10.1158\/0008-5472.CAN-04-0174","volume":"64","author":"YH Min","year":"2004","unstructured":"Min YH, Cheong J-W, Kim JY, Eom JI, Lee ST, Hahn JS, Ko YW, Lee MH (2004) Cytoplasmic mislocalization of p27Kip1 protein is associated with constitutive phosphorylation of Akt or protein kinase B and poor prognosis in acute myelogenous leukemia. Cancer Res 64(15):5225\u20135231","journal-title":"Cancer Res"},{"issue":"8","key":"494_CR76","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1158\/0008-5472.CAN-07-5032","volume":"68","author":"JJ Molenaar","year":"2008","unstructured":"Molenaar JJ, Ebus ME, Koster J, van Sluis P, van Noesel CJ, Versteeg R, Caron HN (2008) Cyclin D1 and CDK4 activity contribute to the undifferentiated phenotype in neuroblastoma. Cancer Res 68(8):2599\u20132609","journal-title":"Cancer Res"},{"issue":"2","key":"494_CR77","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1158\/1078-0432.CCR-13-1569","volume":"20","author":"A Moros","year":"2014","unstructured":"Moros A, Bustany S, Cahu J, Saborit-Villarroya I, Mart\u00ednez A, Colomer D, Sola B, Rou\u00e9 G (2014) Antitumoral activity of lenalidomide in in vitro and in vivo models of mantle cell lymphoma involves the destabilization of cyclin D1\/p27KIP1 complexes. Clin Cancer Res 20(2):393\u2013403","journal-title":"Clin Cancer Res"},{"issue":"8","key":"494_CR78","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1002\/ijc.28206","volume":"133","author":"A M\u00fcller","year":"2013","unstructured":"M\u00fcller A, Zang C, Chumduri C, D\u00f6rken B, Daniel PT, Scholz CW (2013) Concurrent inhibition of PI3K and mTORC1\/mTORC2 overcomes resistance to rapamycin induced apoptosis by down-regulation of Mcl-1 in mantle cell lymphoma. Int J Cancer 133(8):1813\u20131824","journal-title":"Int J Cancer"},{"issue":"5","key":"494_CR79","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1600-0714.2005.00310.x","volume":"34","author":"JA Nemes","year":"2005","unstructured":"Nemes JA, Nemes Z, M\u00e1rton IJ (2005) p21WAF1\/CIP1 expression is a marker of poor prognosis in oral squamous cell carcinoma. J Oral Pathol Med 34(5):274\u2013279","journal-title":"J Oral Pathol Med"},{"issue":"7","key":"494_CR80","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1093\/hmg\/10.7.699","volume":"10","author":"JR Nevins","year":"2001","unstructured":"Nevins JR (2001) The Rb\/E2F pathway and cancer. Hum Mol Genet 10(7):699\u2013703","journal-title":"Hum Mol Genet"},{"issue":"1","key":"494_CR81","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12935-014-0074-z","volume":"14","author":"C-C Niu","year":"2014","unstructured":"Niu C-C, Zhao C, Yang Z, Zhang X-L, Pan J, Si W-K (2014) Inhibiting CCN1 blocks AML cell growth by disrupting the MEK\/ERK pathway. Cancer Cell Int 14(1):74\u201374","journal-title":"Cancer Cell Int"},{"issue":"4","key":"494_CR82","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4172\/1948-5956.1000112","volume":"4","author":"TM Nordgren","year":"2012","unstructured":"Nordgren TM, Hegde GV, Joshi SS (2012) Ritonavir exhibits limited efficacy as a single agent in treating aggressive mantle cell lymphoma. J Cancer Sci Ther 4(4):61\u201368","journal-title":"J Cancer Sci Ther"},{"issue":"1","key":"494_CR83","first-page":"270","volume":"2007","author":"OA O\u2019Connor","year":"2007","unstructured":"O\u2019Connor OA (2007) Mantle cell lymphoma: identifying novel molecular targets in growth and survival pathways. ASH Education Program Book 2007(1):270\u2013276","journal-title":"ASH Education Program Book"},{"issue":"42","key":"494_CR84","doi-asserted-by":"publisher","first-page":"12150","DOI":"10.3748\/wjg.v21.i42.12150","volume":"21","author":"S Ohkoshi","year":"2015","unstructured":"Ohkoshi S, Yano M, Matsuda Y (2015) Oncogenic role of p21 in hepatocarcinogenesis suggests a new treatment strategy. World J Gastroenterol 21(42):12150\u201312156","journal-title":"World J Gastroenterol"},{"issue":"1","key":"494_CR85","first-page":"59","volume":"33","author":"J O'Kelly","year":"2008","unstructured":"O'Kelly J, Chung A, Lemp N, Chumakova K, Yin D, Wang H-J, Said J, Gui D, Miller CW, Karlan BY (2008) Functional domains of CCN1 (Cyr61) regulate breast cancer progression. Int J Oncol 33(1):59\u201367","journal-title":"Int J Oncol"},{"issue":"21","key":"494_CR86","doi-asserted-by":"publisher","first-page":"9705","DOI":"10.1158\/0008-5472.CAN-05-0982","volume":"65","author":"UR Pendurthi","year":"2005","unstructured":"Pendurthi UR, Tran TT, Post M, Rao LVM (2005) Proteolysis of CCN1 by plasmin: functional implications. Cancer Res 65(21):9705\u20139711","journal-title":"Cancer Res"},{"issue":"2","key":"494_CR87","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0168-8278(98)80014-7","volume":"29","author":"S-Y Peng","year":"1998","unstructured":"Peng S-Y, Chou S-P, Hsu H-C (1998) Association of downregulation of cyclin D1 and of overexpression of cyclin E with p53 mutation, high tumor grade and poor prognosis in hepatocellular carcinoma. J Hepatol 29(2):281\u2013289","journal-title":"J Hepatol"},{"issue":"2","key":"494_CR88","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1136\/mp.52.2.84","volume":"52","author":"B Perbal","year":"1999","unstructured":"Perbal B (1999) Nuclear localisation of NOVH protein: a potential role for NOV in the regulation of gene expression. Mol Pathol 52(2):84\u201391","journal-title":"Mol Pathol"},{"issue":"2","key":"494_CR89","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s12079-009-0051-9","volume":"3","author":"B Perbal","year":"2009","unstructured":"Perbal B (2009) Alternative splicing of CCN mRNAs\u2026. It has been upon us. J Cell Commun Signal 3(2):153\u2013157","journal-title":"J Cell Commun Signal"},{"issue":"1","key":"494_CR90","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1182\/blood-2010-04-189977","volume":"117","author":"P P\u00e9rez-Gal\u00e1n","year":"2011","unstructured":"P\u00e9rez-Gal\u00e1n P, Dreyling M, Wiestner A (2011) Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era. Blood 117(1):26\u201338","journal-title":"Blood"},{"issue":"19","key":"494_CR91","doi-asserted-by":"publisher","first-page":"5310","DOI":"10.1093\/emboj\/18.19.5310","volume":"18","author":"I Perez-Roger","year":"1999","unstructured":"Perez-Roger I, Kim SH, Griffiths B, Sewing A, Land H (1999) Cyclins D1 and D2 mediate Myc-induced proliferation via sequestration of p27Kip1 and p21Cip1. EMBO J 18(19):5310\u20135320","journal-title":"EMBO J"},{"issue":"2","key":"494_CR92","doi-asserted-by":"publisher","first-page":"e219","DOI":"10.4317\/medoral.18213","volume":"18","author":"M P\u00e9rez-Say\u00e1ns","year":"2013","unstructured":"P\u00e9rez-Say\u00e1ns M, Su\u00e1rez-Pe\u00f1aranda JM, Gayoso-Diz P, Barros-Angueira F, G\u00e1ndara-Rey JM, Garc\u00eda-Garc\u00eda A (2013) The role of p21Waf1\/CIP1 as a Cip\/Kip type cell-cycle regulator in oral squamous cell carcinoma (review). Med Oral Patol Oral Cir Bucal 18(2):e219","journal-title":"Med Oral Patol Oral Cir Bucal"},{"issue":"1","key":"494_CR93","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4161\/cc.1.1.98","volume":"1","author":"ND Perkins","year":"2002","unstructured":"Perkins ND (2002) Not just a CDK inhibitor: regulation of transcription by p21WAF1\/CIP1\/SDI1. Cell Cycle 1(1):35\u201337","journal-title":"Cell Cycle"},{"issue":"2","key":"494_CR94","doi-asserted-by":"crossref","first-page":"189","DOI":"10.6000\/1929-2279.2012.01.02.5","volume":"1","author":"MT Piccolo","year":"2012","unstructured":"Piccolo MT, Crispi S (2012) The dual role played by p21 may influence the apoptotic or anti-apoptotic fate in cancer. J Cancer Res Updates 1(2):189\u2013202","journal-title":"J Cancer Res Updates"},{"issue":"1","key":"494_CR95","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1478-811X-4-7","volume":"4","author":"N Planque","year":"2006","unstructured":"Planque N (2006) Nuclear trafficking of secreted factors and cell-surface receptors: new pathways to regulate cell proliferation and differentiation, and involvement in cancers. Cell Commun Signal 4(1):7","journal-title":"Cell Commun Signal"},{"issue":"1","key":"494_CR96","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1475-2867-3-15","volume":"3","author":"N Planque","year":"2003","unstructured":"Planque N, Perbal B (2003) A structural approach to the role of CCN (CYR61\/CTGF\/NOV) proteins in tumourigenesis. Cancer Cell Int 3(1):15","journal-title":"Cancer Cell Int"},{"issue":"1","key":"494_CR97","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/jcb.20887","volume":"99","author":"N Planque","year":"2006","unstructured":"Planque N, Long Li C, Saule S, Bleau AM, Perbal B (2006) Nuclear addressing provides a clue for the transforming activity of amino-truncated CCN3 proteins. J Cell Biochem 99(1):105\u2013116","journal-title":"J Cell Biochem"},{"issue":"8","key":"494_CR98","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1053\/hupa.2001.27105","volume":"32","author":"L-F Qin","year":"2001","unstructured":"Qin L-F, Ng I O-l (2001) Expression of p27 KIP1 and p21 WAF1\/CIP1 in primary hepatocellular carcinoma: clinicopathologic correlation and survival analysis. Hum Pathol 32(8):778\u2013785","journal-title":"Hum Pathol"},{"issue":"5","key":"494_CR99","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.ccell.2016.09.014","volume":"30","author":"AC Queir\u00f3s","year":"2016","unstructured":"Queir\u00f3s AC, Beekman R, Vilarrasa-Blasi R, Duran-Ferrer M, Clot G, Merkel A, Raineri E, Russi\u00f1ol N, Castellano G, Be\u00e0 S, Navarro A, Kulis M, Verdaguer-Dot N, Jares P, Enjuanes A, Calasanz MJ, Bergmann A, Vater I, Salaverr\u00eda I, vane de Werken HJG, Wilson WH, Datta A, Flicek P, Royo R, Martens J, Gin\u00e9 E, Lopez-Guillermo A, Stunnenberg HG, Klapper W, Pott C, Heath S, Gut IG, Siebert R, Campo E, Mart\u00edn-Subero JI (2016) Decoding the DNA Methylome of mantle cell lymphoma in the light of the entire B cell lineage. Cancer Cell 30(5):806\u2013821","journal-title":"Cancer Cell"},{"issue":"7","key":"494_CR100","first-page":"2799","volume":"30","author":"AB Queiroz","year":"2010","unstructured":"Queiroz AB, Focchi G, Dobo C, Gomes TS, Ribeiro DA, Oshima CT (2010) Expression of P27, P21WAF\/Cip1, and P16INK4a in normal oral epithelium, oral squamous papilloma, and oral squamous cell carcinoma. Anticancer Res 30(7):2799\u20132803","journal-title":"Anticancer Res"},{"issue":"1","key":"494_CR101","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0002-9440(10)65558-7","volume":"153","author":"L Quintanilla-Martinez","year":"1998","unstructured":"Quintanilla-Martinez L, Thieblemont C, Fend F, Kumar S, Pinyol M, Campo E, Jaffe ES, Raffeld M (1998) Mantle cell lymphomas lack expression of p27 Kip1, a cyclin-dependent kinase inhibitor. Am J Pathol 153(1):175\u2013182","journal-title":"Am J Pathol"},{"issue":"8","key":"494_CR102","first-page":"3181","volume":"101","author":"L Quintanilla-Martinez","year":"2003","unstructured":"Quintanilla-Martinez L, Davies-Hill T, Fend F, Calzada-Wack J, Sorbara L, Campo E, Jaffe ES, Raffeld M (2003) Sequestration of p27 Kip1 protein by cyclin D1 in typical and blastic variants of mantle cell lymphoma (MCL): implications for pathogenesis. Blood-New York 101(8):3181\u20133187","journal-title":"Blood-New York"},{"issue":"3","key":"494_CR103","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/bjh.13973","volume":"173","author":"H Rauert-Wunderlich","year":"2016","unstructured":"Rauert-Wunderlich H, Rudelius M, Ott G, Rosenwald A (2016) Targeting protein kinase C in mantle cell lymphoma. Br J Haematol 173(3):394\u2013403","journal-title":"Br J Haematol"},{"issue":"4","key":"494_CR104","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1128\/MCB.00898-08","volume":"29","author":"A Ray","year":"2009","unstructured":"Ray A, James MK, Larochelle S, Fisher RP, Blain SW (2009) p27Kip1 inhibits cyclin D-cyclin-dependent kinase 4 by two independent modes. Mol Cell Biol 29(4):986\u2013999","journal-title":"Mol Cell Biol"},{"issue":"6","key":"494_CR105","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1134\/S000629791206003X","volume":"77","author":"V Romanov","year":"2012","unstructured":"Romanov V, Pospelov V, Pospelova T (2012) Cyclin-dependent kinase inhibitor p21Waf1: contemporary view on its role in senescence and oncogenesis. Biochem Mosc 77(6):575\u2013584","journal-title":"Biochem Mosc"},{"issue":"1","key":"494_CR106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0304-3835(01)00847-3","volume":"179","author":"IB Roninson","year":"2002","unstructured":"Roninson IB (2002) Oncogenic functions of tumour suppressor p21 Waf1\/Cip1\/Sdi1: association with cell senescence and tumour-promoting activities of stromal fibroblasts. Cancer Lett 179(1):1\u201314","journal-title":"Cancer Lett"},{"issue":"13","key":"494_CR107","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1182\/blood-2014-08-592303","volume":"124","author":"GD Roodman","year":"2014","unstructured":"Roodman GD (2014) CCN1: a sticky issue in myeloma. Blood 124(13):2006\u20132008","journal-title":"Blood"},{"issue":"12","key":"494_CR108","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.4161\/cc.7.12.6024","volume":"7","author":"S Roy","year":"2008","unstructured":"Roy S, Singh RP, Agarwal C, Siriwardana S, Sclafani RA, Agarwal R (2008) Downregulation of both p21\/Cip1 and p27\/Kip1 produces a more aggressive prostate cancer phenotype. Cell Cycle 7(12):1828\u20131835","journal-title":"Cell Cycle"},{"issue":"8","key":"494_CR109","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1038\/leu.2012.72","volume":"26","author":"C Royo","year":"2012","unstructured":"Royo C, Navarro A, Clot G, Salaverria I, Gin\u00e9 E, Jares P, Colomer D, Wiestner A, Wilson WH, Vegliante MC, Fernandez V, Hartmann EM, Trim N, Erber WN, Swerdlow SH, Klapper W, Dyer MJ, Vargas-Pab\u00f3n M, Ott G, Rosenwald A, Siebert R, L\u00f3pez-Guillermo A, Campo E, Be\u00e0 S (2012) Non-nodal type of mantle cell lymphoma isa specific biological and clinical subgroup of the disease. Leukemia 26(8):1895\u20131898","journal-title":"Leukemia"},{"issue":"2","key":"494_CR110","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.cancergencyto.2004.01.006","volume":"153","author":"C Rudolph","year":"2004","unstructured":"Rudolph C, Steinemann D, Von Neuhoff N, Gadzicki D, Ripperger T, Drexler HG, Mrasek K, Liehr T, Claussen U, Emura M, Schrock E, Schlegelberger B (2004) Molecular cytogenetic characterization of the mantle cell lymphoma cell line GRANTA-519. Cancer Genet Cytogenet 153(2):144\u2013150","journal-title":"Cancer Genet Cytogenet"},{"issue":"6","key":"494_CR111","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.humpath.2014.02.007","volume":"45","author":"O Saglam","year":"2014","unstructured":"Saglam O, Dai F, Husain S, Zhan Y, Toruner G, Haines GK (2014) Matricellular protein CCN1 (CYR61) expression is associated with high-grade ductal carcinoma in situ. Hum Pathol 45(6):1269\u20131275","journal-title":"Hum Pathol"},{"issue":"124","key":"494_CR112","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1182\/blood.V124.21.2148.2148","volume":"2014","author":"F Samaniego","year":"2014","unstructured":"Samaniego F, Sehgal L, Braun FK, Berkova Z, Romaguera JE, Wang M, Rodriguez A, Neelapu SS, Mathur R (2014) Molecular signatures of tumor-initiating cells unveil wnt pathway as a therapeutic target in mantle cell lymphoma. Blood 2014(124):2148","journal-title":"Blood"},{"issue":"4","key":"494_CR113","doi-asserted-by":"publisher","first-page":"F1363","DOI":"10.1152\/ajprenal.00205.2007","volume":"293","author":"K Sawai","year":"2007","unstructured":"Sawai K, Mukoyama M, Mori K, Kasahara M, Koshikawa M, Yokoi H, Yoshioka T, Ogawa Y, Sugawara A, Nishiyama H (2007) Expression of CCN1 (CYR61) in developing, normal, and diseased human kidney. Am J Physiol Renal Physiol 293(4):F1363\u2013F1372","journal-title":"Am J Physiol Renal Physiol"},{"issue":"8","key":"494_CR114","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1128\/MCB.26.8.2955-2964.2006","volume":"26","author":"W Si","year":"2006","unstructured":"Si W, Kang Q, Luu HH, Park JK, Luo Q, Song W-X, Jiang W, Luo X, Li X, Yin H (2006) CCN1\/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells. Mol Cell Biol 26(8):2955\u20132964","journal-title":"Mol Cell Biol"},{"issue":"2","key":"494_CR115","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2217\/fon.10.189","volume":"7","author":"MR Smith","year":"2011","unstructured":"Smith MR (2011) Should there be a standard therapy for mantle cell lymphoma? Future Oncol 7(2):227\u2013237","journal-title":"Future Oncol"},{"issue":"23","key":"494_CR116","doi-asserted-by":"publisher","first-page":"11254","DOI":"10.1158\/0008-5472.CAN-06-1569","volume":"66","author":"D Sohn","year":"2006","unstructured":"Sohn D, Essmann F, Schulze-Osthoff K, J\u00e4nicke RU (2006) p21 blocks irradiation-induced apoptosis downstream of mitochondria by inhibition of cyclin-dependent kinase\u2013mediated caspase-9 activation. Cancer Res 66(23):11254\u201311262","journal-title":"Cancer Res"},{"issue":"10","key":"494_CR117","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1038\/sj.bjc.6604712","volume":"99","author":"Z Sun","year":"2008","unstructured":"Sun Z, Wang Y, Cai Z, Chen P, Tong X, Xie D (2008) Involvement of Cyr61 in growth, migration, and metastasis of prostate cancer cells. Br J Cancer 99(10):1656\u20131667","journal-title":"Br J Cancer"},{"issue":"20","key":"494_CR118","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127(20):2375\u20132390","journal-title":"Blood"},{"key":"494_CR119","doi-asserted-by":"publisher","first-page":"C1524","DOI":"10.1152\/ajpcell.2001.281.5.C1524","volume":"281","author":"I Tamura","year":"2001","unstructured":"Tamura I, Rosenbloom J, Macarak E, Chaqour B (2001) Regulation of Cyr61 gene expression by mechanical stretch through multiple signaling pathways. Am J Physiol Cell Physiol 281:C1524\u2013C1532","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"494_CR120","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s12079-014-0229-7","volume":"8","author":"K Thompson","year":"2014","unstructured":"Thompson K, Murphy-Marshman H, Leask A (2014) ALK5 inhibition blocks TGF\u03b2-induced CCN1 expression in human foreskin fibroblasts. J Cell Commun Signal 8(1):59\u201363","journal-title":"J Cell Commun Signal"},{"issue":"38","key":"494_CR121","doi-asserted-by":"publisher","first-page":"14009","DOI":"10.1073\/pnas.0606316103","volume":"103","author":"I Timmerbeul","year":"2006","unstructured":"Timmerbeul I, Garrett-Engele CM, Kossatz U, Chen X, Firpo E, Gr\u00fcnwald V, Kamino K, Wilkens L, Lehmann U, Buer J (2006) Testing the importance of p27 degradation by the SCFskp2 pathway in murine models of lung and colon cancer. Proc Natl Acad Sci 103(38):14009\u201314014","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"494_CR122","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1083\/jcb.200504015","volume":"171","author":"V Todorovic\u00e7","year":"2005","unstructured":"Todorovic\u00e7 V, Chen C-C, Hay N, Lau LF (2005) The matrix protein CCN1 (CYR61) induces apoptosis in fibroblasts. J Cell Biol 171(3):559\u2013568","journal-title":"J Cell Biol"},{"issue":"50","key":"494_CR123","doi-asserted-by":"publisher","first-page":"47709","DOI":"10.1074\/jbc.M107878200","volume":"276","author":"X Tong","year":"2001","unstructured":"Tong X, Xie D, O'Kelly J, Miller CW, Muller-Tidow C, Koeffler HP (2001) Cyr61, a member of CCN family, is a tumor suppressor in non-small cell lung cancer. J Biol Chem 276(50):47709\u201347714","journal-title":"J Biol Chem"},{"issue":"28","key":"494_CR124","doi-asserted-by":"publisher","first-page":"4847","DOI":"10.1038\/sj.onc.1207628","volume":"23","author":"X Tong","year":"2004","unstructured":"Tong X, O'Kelly J, Xie D, Mori A, Lemp N, McKenna R, Miller CW, Koeffler HP (2004) Cyr61 suppresses the growth of non-small-cell lung cancer cells via the \u03b2-catenin\u2013c-myc\u2013p53 pathway. Oncogene 23(28):4847\u20134855","journal-title":"Oncogene"},{"issue":"1","key":"494_CR125","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0092-8674(94)90573-8","volume":"78","author":"H Toyoshima","year":"1994","unstructured":"Toyoshima H, Hunter T (1994) p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78(1):67\u201374","journal-title":"Cell"},{"issue":"4","key":"494_CR126","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.leukres.2005.08.016","volume":"30","author":"CA Tucker","year":"2006","unstructured":"Tucker CA, Bebb G, Klasa RJ, Chhanabhai M, Lestou V, Horsman DE, Gascoyne RD, Wiestner A, Masin D, Bally M (2006) Four human t (11; 14)(q13; q32)-containing cell lines having classic and variant features of mantle cell lymphoma. Leuk Res 30(4):449\u2013457","journal-title":"Leuk Res"},{"issue":"6481","key":"494_CR127","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/369574a0","volume":"369","author":"S Waga","year":"1994","unstructured":"Waga S, Hannon GJ, Beach D, Stillman B (1994) The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369(6481):574\u2013578","journal-title":"Nature"},{"issue":"3","key":"494_CR128","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s12079-015-0296-4","volume":"9","author":"J Wells","year":"2015","unstructured":"Wells J, Howlett M, Cheung L, Kees UR (2015) The role of CCN family genes in haematological malignancies. J Cell commun Signal 9(3):267\u2013278","journal-title":"J Cell commun Signal"},{"issue":"6","key":"494_CR129","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1158\/0008-5472.CAN-03-0666","volume":"64","author":"D Xie","year":"2004","unstructured":"Xie D, Yin D, Tong X, O\u2019Kelly J, Mori A, Miller C, Black K, Gui D, Said JW, Koeffler HP (2004a) Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and \u03b2-catenin-TCF\/Lef signaling pathways. Cancer Res 64(6):1987\u20131996","journal-title":"Cancer Res"},{"issue":"6","key":"494_CR130","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1158\/1078-0432.CCR-0659-03","volume":"10","author":"D Xie","year":"2004","unstructured":"Xie D, Yin D, Wang H-J, Liu G-T, Elashoff R, Black K, Koeffler HP (2004b) Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas. Clin Cancer Res 10(6):2072\u20132081","journal-title":"Clin Cancer Res"},{"issue":"4","key":"494_CR131","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1182\/blood-2005-06-2509","volume":"107","author":"VP Yakubenko","year":"2006","unstructured":"Yakubenko VP, Yadav SP, Ugarova TP (2006) Integrin \u03b1 D \u03b2 2, an adhesion receptor up-regulated on macrophage foam cells, exhibits multiligand-binding properties. Blood 107(4):1643\u20131650","journal-title":"Blood"},{"issue":"6","key":"494_CR132","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1021\/tx300059m","volume":"25","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Yan B (2012) Cell cycle regulation by carboxylated multiwalled carbon nanotubes through p53-independent induction of p21 under the control of the BMP signaling pathway. Chem Res Toxicol 25(6):1212\u20131221","journal-title":"Chem Res Toxicol"},{"issue":"15_suppl","key":"494_CR133","doi-asserted-by":"publisher","first-page":"22150","DOI":"10.1200\/jco.2008.26.15_suppl.22150","volume":"26","author":"L Zhang","year":"2008","unstructured":"Zhang L, Schafer P, Muller G, Stirling D, Bartlett B (2008) The ratio of cyclin D1\/p21kip baseline gene expression and SPARC gene expression can be potential predictors of non-Hodgkin's lymphoma (NHL) patient response to lenalidomide therapy. J Clin Oncol 26(15_suppl):22150\u201322150","journal-title":"J Clin Oncol"},{"issue":"24","key":"494_CR134","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2871","volume":"5","author":"H Zhao","year":"2014","unstructured":"Zhao H, Faltermeier CM, Mendelsohn L, Porter PL, Clurman BE, Roberts JM (2014) Mislocalization of p27 to the cytoplasm of breast cancer cells confers resistance to anti-HER2 targeted therapy. Oncotarget 5(24):12704","journal-title":"Oncotarget"},{"issue":"1","key":"494_CR135","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/(SICI)1097-0215(20000120)89:1<14::AID-IJC3>3.0.CO;2-L","volume":"89","author":"TK Zirbes","year":"2000","unstructured":"Zirbes TK, Baldus SE, Moenig SP, Nolden S, Kunze D, Shafizadeh ST, Schneider PM, Thiele J, Hoelscher AH, Dienes HP (2000) Prognostic impact of p21\/waf1\/cip1 in colorectal cancer. Int J Cancer 89(1):14\u201318","journal-title":"Int J Cancer"},{"issue":"6","key":"494_CR136","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1056\/NEJMe1307596","volume":"369","author":"E Zucca","year":"2013","unstructured":"Zucca E, Bertoni F (2013) Toward new treatments for mantle-cell lymphoma? N Engl J Med 369(6):571\u2013572","journal-title":"N Engl J Med"}],"container-title":["Journal of Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12079-018-0494-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12079-018-0494-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12079-018-0494-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T19:07:41Z","timestamp":1702667261000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12079-018-0494-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,21]]},"references-count":136,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["494"],"URL":"https:\/\/doi.org\/10.1007\/s12079-018-0494-y","relation":{},"ISSN":["1873-9601","1873-961X"],"issn-type":[{"value":"1873-9601","type":"print"},{"value":"1873-961X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,21]]},"assertion":[{"value":"12 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}